EU Number 
(Invented) 
name 
Strength 
Pharmaceutical 
Form 
Route of 
Administration 
Immediate 
Packaging 
Content 
(concentration) 
Pack size 
EU/1/21/1577/001 
Voxzogo   
0.4 mg 
EU/1/21/1577/002 
Voxzogo   
0.56 mg 
EU/1/21/1577/003 
Voxzogo   
1.2 mg 
Powder and 
solvent for 
solution for 
injection 
Powder and 
solvent for 
solution for 
injection 
Powder and 
solvent for 
solution for 
injection 
Subcutaneous 
use 
Subcutaneous 
use 
Subcutaneous 
use 
powder: vial 
(glass); solvent: 
pre-filled syringe 
(glass) 
Powder for 
solution: 0.4 mg; 
Solvent: 0.5 ml; 
(0.8 mg/ml) 
powder: vial 
(glass); solvent: 
pre-filled syringe 
(glass) 
Powder for 
solution: 0.56 
mg; Solvent: 0.7 
ml; (0.8 mg/ml) 
powder: vial 
(glass); solvent: 
pre-filled syringe 
(glass) 
Powder for 
solution: 1.2 mg; 
Solvent: 0.6 ml; 
(2 mg/ml) 
10 vials + 10 pre-
filled syringes + 
10 needles + 10 
administration 
syringes  
10 vials + 10 pre-
filled syringes + 
10 needles + 10 
administration 
syringes  
10 vials + 10 pre-
filled syringes + 
10 needles + 10 
administration 
syringes  
 
 
 
 
 
 
 
 
 
 
 
 
 
